Vistakon

Industry

  • Pharmaceuticals
    • OTC, Consumer
  • Medical Devices
See more in Biomedtracker

Latest on Vistakon

Pink Sheet

Together Rx Patient Assistance Program Will Close When ACA Coverage Expansion Begins

 
• By Cathy Kelly

The Together Rx Access patient assistance program sponsored by a group of large pharmaceutical manufacturers has announced it will close at the end of 2013 because those being helped through the progr

Medtech Insight

Bausch & Lomb Sold To Valeant Pharmaceuticals For $8.7 Billion

Valeant Pharmaceuticals International Inc. is poised to be a major player in the ophthalmic device and drug market with its agreement to pay $8.7 billion in debt and equity to acquire privately held

HBW Insight

Eye On The Prize: For $8.7 Billion, Valeant Will Acquire Bausch & Lomb

Generics powerhouse Allergan PLC may have said no, but Valeant Pharmaceuticals International Inc. CEO Michael Pearson always seems to have another vision, even if he needs to adjust his horizo

Pink Sheet

Eye On The Prize: For $8.7 Billion, Valeant Will Acquire Bausch & Lomb

Generics powerhouse Allergan PLC may have said no, but Valeant Pharmaceuticals International Inc. CEO Michael Pearson always seems to have another vision, even if he needs to adjust his horizo